Interleukin-17 (IL-17) has been associated with the pathogenesis of T1DM and our in vitro study found that GMSCs had the ability to inhibit Th17/Tc17 cells differentiation16, so we wondered whether GMSCs could suppress IL-17 expression in T1DM. This evidence concerns the gene IL17A and type 1 diabetes mellitus.